Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Rheumatoid Arthritis

Free Subscription 23.04.2018 2 Ann Rheum Dis 6 Clin Rheumatol 3 J Rheumatol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Rheum Dis

1. BOER AC, Boeters DM, van der Helm-van Mil AHM
   The use of MRI-detected synovitis to determine the number of involved joints for the 2010 ACR/EULAR classification criteria for Rheumatoid Arthritis - is it of additional benefit?
   Ann Rheum Dis. 2018 Apr 20. pii: annrheumdis-2018-213143.
   PubMed     Text format     Abstract available
   
   
2. CHEN YM, Liao TL, Chen HH, Chen DY, et al
   Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
   Ann Rheum Dis. 2018 Apr 19. pii: annrheumdis-2018-213097.
   PubMed     Text format    
   
   

   
   Clin Rheumatol

3. HURNAKOVA J, Hulejova H, Zavada J, Komarc M, et al
   Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.
   Clin Rheumatol. 2018 Apr 14. pii: 10.1007/s10067-018-4091.
   PubMed     Text format     Abstract available
   
   
4. STRAND V, Lee EB, Yazici Y, Dikranian A, et al
   Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials.
   Clin Rheumatol. 2018 Apr 14. pii: 10.1007/s10067-018-4077.
   PubMed     Text format     Abstract available
   
   
5. GAO H, Ma XX, Guo Q, Xie LF, et al
   Expression of circulating Semaphorin3A and its association with inflammation and bone destruction in rheumatoid arthritis.
   Clin Rheumatol. 2018 Apr 14. pii: 10.1007/s10067-018-4070.
   PubMed     Text format     Abstract available
   
   
6. TYMMS K, Littlejohn G, Griffiths H, de Jager J, et al
   Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors.
   Clin Rheumatol. 2018 Apr 18. pii: 10.1007/s10067-018-4105.
   PubMed     Text format     Abstract available
   
   
7. LUO Y, Fan X, Jiang C, Arevalo Molina AB, et al
   Rheumatoid arthritis is associated with increased in-hospital mortality in asthma exacerbations: a nationwide study.
   Clin Rheumatol. 2018 Apr 19. pii: 10.1007/s10067-018-4114.
   PubMed     Text format     Abstract available
   
   
8. QUINTANA R, Goni M, Mathern N, Jorfen M, et al
   Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort study.
   Clin Rheumatol. 2018 Apr 19. pii: 10.1007/s10067-018-4103.
   PubMed     Text format     Abstract available
   
   

   
   J Rheumatol

9. GENOVESE MC, Pacheco-Tena C, Covarrubias A, Leon G, et al
   Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial.
   J Rheumatol. 2018 Apr 15. pii: jrheum.170344. doi: 10.3899/jrheum.170344.
   PubMed     Text format     Abstract available
   
   
10. BRADHAM W, Ormseth MJ, Elumogo C, Palanisamy S, et al
    Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170770. doi: 10.3899/jrheum.170770.
    PubMed     Text format     Abstract available
    
    
11. SAKURAI K, Ishigaki K, Shoda H, Nagafuchi Y, et al
    HLA-DRB1 Shared Epitope Alleles and Disease Activity Are Correlated with Reduced T Cell Receptor Repertoire Diversity in CD4+ T Cells in Rheumatoid Arthritis.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170909. doi: 10.3899/jrheum.170909.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: